Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Markus Hutterer, Fro-Philip Wirtz et al.|Cancers|2020Cited by 45
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous MetaboliteRaffaela S. Berger, Katja Dettmer, Anuhar Chaturvedi et al.|Cancers|2021Cited by 10
Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1H-Magnetic Resonance Spectroscopy and Machine LearningElisabeth Bumes, Markus Hutterer, Claudia Fellner et al.|Cancers|2022Cited by 6
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patientsAlexander Scheiter, Kirsten Utpatel, Simon Mellin et al.|BMC Medicine|2026Cited by 2
Palliative care interventions and outcome in patients with glioblastoma – a retrospective, single-center studyLisa-Marie Lind, Elisabeth Bumes, Anna Fischl et al.|BMC Palliative Care|2026Cited by 1